导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.32% | 838/1050 |
| 近一周 | -1.36% | 532/1104 |
| 近一月 | -4.54% | 721/1103 |
| 近一季 | -23.79% | 1040/1092 |
| 近半年 | -11.52% | 818/1070 |
| 近一年 | -8.97% | 728/1018 |
| 近两年 | 53.06% | 494/926 |
| 近三年 | 21.12% | 487/834 |
| 成立以来 | 64.60% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.42% 926/1070 |
30.37% 312/1101 |
- - |
- - |
| 2025 | 34.95% 397/1065 |
-0.08% 800/1014 |
3.59% 388/1038 |
32.07% 335/1050 |
-1.28% 515/1065 |
| 2024 | 1.27% 545/1011 |
2.53% 185/960 |
-9.06% 832/983 |
8.15% 767/991 |
0.42% 294/1011 |
| 2023 | 6.38% 37/952 |
10.51% 101/880 |
18.46% 3/895 |
-14.96% 774/915 |
-4.44% 445/952 |
| 2022 | -22.11% 411/867 |
-19.10% 471/773 |
4.50% 547/806 |
-9.35% 204/845 |
1.64% 346/867 |
| 2021 | -1.18% 368/740 |
-9.20% 472/580 |
9.60% 367/659 |
-10.63% 524/704 |
11.12% 52/740 |
| 2020 | 25.63% 365/554 |
-4.17% 264/419 |
22.48% 241/466 |
5.70% 350/517 |
1.26% 479/554 |
| 2019 | 33.68% 271/410 |
31.71% 282/1149 |
-12.35% 1148/1231 |
6.54% 171/390 |
8.69% 210/410 |
| 2018 | -21.58% 98/349 |
- - |
- - |
- - |
-6.00% 82/1080 |
| 2017 | 3.39% 164/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 鹏华文化传媒娱乐股票 VS. 东吴新产业精选股票A(580008) |